ipilimumab,nivolumab,cabozantinib
exelixis,bms
['rcc,(-irccs),(-srcc),(-urcc)', 'cosmic-313']
 who s had his hands on nearly all drugs approved for #rcc going first in presidential symposium #cosmic-313 at #esmo2022 
SWOG Melanoma Chair, Med Onc at MD Anderson Cancer Center.  Tweets are my own.